Stock Scorecard
Stock Summary for XOMA Corp (XOMA) - $26.62 as of 9/6/2024 3:17:16 PM EST
Total Score
9 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for XOMA
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for XOMA
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for XOMA
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for XOMA
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Latest News for for XOMA
Financial Details for XOMA
Company Overview |
|
|---|---|
| Ticker | XOMA |
| Company Name | XOMA Corp |
| Country | USA |
| Description | XOMA Corporation, a biotech royalty aggregator, discovers and develops therapeutic candidates in the United States, Europe, and Asia Pacific. The company is headquartered in Emeryville, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | PHARMACEUTICAL PREPARATIONS |
| Most Recent Quarter | 6/30/2024 |
| Next Earnings Date | 11/5/2024 |
Stock Price History |
|
| Last Day Price | 26.62 |
| Last Day Price Updated | 9/6/2024 3:17:16 PM EST |
| Last Day Volume | 30,223 |
| Average Daily Volume | 22,666 |
| 52-Week High | 30.36 |
| 52-Week Low | 13.48 |
| Last Price to 52 Week Low | 97.48% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 34.82 |
| Sector PE | 80.12 |
| 5-Year Average PE | -190.63 |
| Free Cash Flow Ratio | 2.16 |
| Industry Free Cash Flow Ratio | 13.19 |
| Sector Free Cash Flow Ratio | 30.42 |
| Current Ratio Most Recent Quarter | 8.71 |
| Total Cash Per Share | 12.35 |
| Book Value Per Share Most Recent Quarter | 8.57 |
| Price to Book Ratio | 3.12 |
| Industry Price to Book Ratio | 6.02 |
| Sector Price to Book Ratio | 22.15 |
| Price to Sales Ratio Twelve Trailing Months | 20.95 |
| Industry Price to Sales Ratio Twelve Trailing Months | 7.56 |
| Sector Price to Sales Ratio Twelve Trailing Months | 6.66 |
Share Statistics |
|
| Total Shares Outstanding | 11,704,500 |
| Market Capitalization | 311,573,790 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | 4/2/2024 |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.54 |
| Total Years Dividend Increasing | 0 |
| Trailing Annual Dividend Rate | 0.54 |
| Trailing Annual Dividend Yield | 1.98% |
| Forward Annual Dividend Rate | 0.54 |
| Forward Annual Dividend Yield | 1.98% |
| 5-Year Dividend Payments Count | 1 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | -25.19% |
Income Statement |
|
| Quarterly Earnings Growth YOY | 37.00% |
| Annual Earnings Growth | -138.72% |
| Reported EPS 12 Trailing Months | -2.20 |
| Reported EPS Past Year | -0.02 |
| Reported EPS Prior Year | -2.16 |
| Net Income Twelve Trailing Months | -18,228,000 |
| Net Income Past Year | -40,831,000 |
| Net Income Prior Year | -17,104,000 |
| Quarterly Revenue Growth YOY | 569.00% |
| 5-Year Revenue Growth | -2.13% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 144,600,000 |
| Total Cash Past Year | 153,451,000 |
| Total Cash Prior Year | 58,161,000 |
| Net Cash Position Most Recent Quarter | 29,523,000 |
| Net Cash Position Past Year | 34,933,000 |
| Long Term Debt Past Year | 118,518,000 |
| Long Term Debt Prior Year | 0 |
| Total Debt Most Recent Quarter | 115,077,000 |
| Equity to Debt Ratio Past Year | 0.43 |
| Equity to Debt Ratio Most Recent Quarter | 0.46 |
| Total Stockholder Equity Past Year | 88,721,000 |
| Total Stockholder Equity Prior Year | 124,014,000 |
| Total Stockholder Equity Most Recent Quarter | 99,993,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -22,930,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.96 |
| Free Cash Flow Past Year | -18,175,000 |
| Free Cash Flow Prior Year | -28,126,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | None |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.76 |
| MACD Signal | 0.75 |
| 20-Day Bollinger Lower Band | 22.60 |
| 20-Day Bollinger Middle Band | 26.01 |
| 20-Day Bollinger Upper Band | 29.42 |
| Beta | 0.92 |
| RSI | 53.45 |
| 50-Day SMA | 22.15 |
| 150-Day SMA | 20.84 |
| 200-Day SMA | 24.10 |
System |
|
| Modified | 9/7/2024 5:20:32 PM EST |